Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Ovarian Neoplasms × inavolisib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 2 Solid Tumors 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 HER2-positive Breast Cancer 1 Colorectal Neoplasms 1

Interventions

Paclitaxel 111 Carboplatin 109 Bevacizumab 74 Gemcitabine 35 pembrolizumab 34 olaparib 30 Cisplatin 26 Cyclophosphamide 25 niraparib 23 Docetaxel 23 liposomal doxorubicin 22 Topotecan 21 Etoposide 17 Doxorubicin 14 apatinib 11 Taxes 11 Immunoglobulin G 11 Drug Therapy 11 Disulfides 11 Letrozole 10 Filgrastim 10 Albumin-Bound Paclitaxel 10 fluzoparib 9 fludarabine 9 Cytoreduction Surgical Procedures 8 Biopsy 8 durvalumab 7 Specimen Handling 7 Oxaliplatin 7 Magnetic Resonance Spectroscopy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04931342 2026-03-10

BOUQUET

Hoffmann-La Roche

Phase 2 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡